Literature DB >> 20558227

A review of the epidemiologic evidence concerning the reproductive health effects of caffeine consumption: a 2000-2009 update.

Jennifer David Peck1, Alan Leviton, Linda D Cowan.   

Abstract

This review of human studies of caffeine and reproductive health published between January 2000 and December 2009 serves to update the comprehensive review published by Leviton and Cowan (2002). The adverse reproductive outcomes addressed in this review include: (1) measures of subfecundity; (2) spontaneous abortion; (3) fetal death; (4) preterm birth; (5) congenital malformations; and (6) fetal growth restriction. Methodologic challenges and considerations relevant to investigations of each reproductive endpoint are summarized, followed by a brief critical review of each study. The evidence for an effect of caffeine on reproductive health and fetal development is limited by the inability to rule out plausible alternative explanations for the observed associations, namely confounding by pregnancy symptoms and smoking, and by exposure measurement error. Because of these limitations, the weight of evidence does not support a positive relationship between caffeine consumption and adverse reproductive or perinatal outcomes. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20558227     DOI: 10.1016/j.fct.2010.06.019

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  31 in total

1.  Predictors of pregnancy and live birth after insemination in couples with unexplained or male-factor infertility.

Authors:  Hao Huang; Karl R Hansen; Pamela Factor-Litvak; Sandra A Carson; David S Guzick; Nanette Santoro; Michael P Diamond; Esther Eisenberg; Heping Zhang
Journal:  Fertil Steril       Date:  2012-01-23       Impact factor: 7.329

2.  Is caffeine consumption safe during pregnancy?

Authors:  Sara Morgan; Gideon Koren; Pina Bozzo
Journal:  Can Fam Physician       Date:  2013-04       Impact factor: 3.275

Review 3.  Diet and fertility: a review.

Authors:  Audrey J Gaskins; Jorge E Chavarro
Journal:  Am J Obstet Gynecol       Date:  2017-08-24       Impact factor: 8.661

Review 4.  Evaluation of the reproductive and developmental risks of caffeine.

Authors:  Robert L Brent; Mildred S Christian; Robert M Diener
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2011-03-02

5.  Caffeinated beverage intake and reproductive hormones among premenopausal women in the BioCycle Study.

Authors:  Karen C Schliep; Enrique F Schisterman; Sunni L Mumford; Anna Z Pollack; Cuilin Zhang; Aijun Ye; Joseph B Stanford; Ahmad O Hammoud; Christina A Porucznik; Jean Wactawski-Wende
Journal:  Am J Clin Nutr       Date:  2012-01-11       Impact factor: 7.045

6.  Caffeine consumption during pregnancy and risk of preterm birth: a meta-analysis.

Authors:  Ekaterina Maslova; Sayanti Bhattacharya; Shih-Wen Lin; Karin B Michels
Journal:  Am J Clin Nutr       Date:  2010-09-15       Impact factor: 7.045

7.  Antioxidant Consumption is Associated with Decreased Odds of Congenital Limb Deficiencies.

Authors:  Nelson D Pace; Tania A Desrosiers; Suzan L Carmichael; Gary M Shaw; Andrew F Olshan; Anna Maria Siega-Riz
Journal:  Paediatr Perinat Epidemiol       Date:  2017-09-04       Impact factor: 3.980

8.  Body mass index at age 20 and subsequent childbearing: the Adventist Health Study-2.

Authors:  Bjarne K Jacobsen; Synnøve F Knutsen; Keiji Oda; Gary E Fraser
Journal:  J Womens Health (Larchmt)       Date:  2013-04-23       Impact factor: 2.681

Review 9.  Novel methylxanthine derivative-mediated anti-inflammatory effects in inflammatory bowel disease.

Authors:  In-Ah Lee; Alan Kamba; Daren Low; Emiko Mizoguchi
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

10.  Caffeine intake during pregnancy and adverse birth outcomes: a systematic review and dose-response meta-analysis.

Authors:  Darren C Greenwood; Natalie J Thatcher; Jin Ye; Lucy Garrard; Georgina Keogh; Laura G King; Janet E Cade
Journal:  Eur J Epidemiol       Date:  2014-09-02       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.